Although NK cells isolated from chronic phase CML patients were found to be BCR/ABL1 negative (108, 109), Nakajima et al. observed BCR/ABL1+ NK cells in advanced phases of the disease (110). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.